Guardant Health, Inc. annual gross profit for fiscal 2025 was $633 million, an increase of 40.9% from $449 million in fiscal 2024. All figures are reported results from public filings — no estimates or projections.
| Gross Profit (annual) | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Gross Profit | $633M | $449M | $337M | $293M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Gross Profit (quarterly) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Gross Profit | $197M | $182M | $172M | $151M | $129M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More GH metrics: Revenue · Operating Income · Net Income · EPS · Free Cash Flow
All GH financial statements → Interactive GH charts →
About TickerBase · Data methodology & sources